
Taren Grom
Editor-in-Chief EmeritusIn 2001, Taren Grom co-founded PharmaVoice, a business-to-business trade publication, which covers the trends and opportunities facing the life sciences industry from molecule to market, and PharmaLinx LLC, a multimedia publishing company. For more than 20 years, Grom served as editor-in-chief, overseeing the annual PharmaVoice 100, the Woman of the Week podcast series, virtual panels and industry-related events. In September 2021, PharmaVoice was acquired by Industry Dive, and Grom now serves as editor-in-chief emeritus of the newly relaunched PharmaVoice, charged with overseeing special projects, virtual panels, the PharmaVoice 100 and WoW podcast. Grom has been a dedicated volunteer to the Healthcare Businesswomen’s Association for more than a decade, serving on multiple committees, including those responsible for the Annual Conference, Woman of the Year event, the Gender Parity Collaborative and Executive Women’s Forum. Grom served on the organization’s corporate board of directors for nine years. She won the prestigious HBA President’s Award in 2013 and STAR volunteer award in 2019.
116 articles by Taren Grom
-
Woman of the Week: RIGImmune’s Susan Sobolov
March 22, 2023 -
A biopharma CEO’s quest for global health equity has put him in the running for a Nobel Prize
March 17, 2023 -
Woman of the Week: Novartis Gene Therapies’ Chris Fox
March 15, 2023 -
IQVIA’s OG of data analytics on the latest clinical trial trends
March 10, 2023 -
Woman of the Week: Lucy Therapeutics’ Amy Ripka
March 8, 2023 -
Targeting the new ‘Golden Girls’
March 8, 2023 -
PharmaVoice 100 honorees: Where are they now?
March 3, 2023 -
Launched with a ‘pioneer’ in RNA, aTyr Pharma is charting a new course in immunology
March 2, 2023 -
Woman of the Week: Denali Therapeutics’ Cindy Dunkle
March 1, 2023 -
Cytokinetics looks to muscle into the cardiovascular market
Feb. 24, 2023 -
Why patient care is a public affair
Feb. 23, 2023 -
Woman of the Week: Alltrna’s Michelle Werner
Feb. 22, 2023 -
Pheast’s new CEO on how its ‘don’t eat me’ platform could deliver next-gen precision immunotherapies
Feb. 17, 2023 -
Woman of the Week: Bristol Myers Squibb’s Ester Banque
Feb. 15, 2023 -
Rocket Pharmaceuticals is ready for liftoff in the rare disease space
Feb. 10, 2023 -
Woman of the Week: KaliVir Immunotherapeutics’ Helena Chaye
Feb. 8, 2023 -
Astria Therapeutics’ edge in an ultra-rare disease
Feb. 1, 2023 -
Woman of the Week: Bayer’s Dr. Yesmean Wahdan
Feb. 1, 2023 -
A biotech CEO’s favorite ‘F’ word
Jan. 26, 2023 -
Woman of the Week: Dr. Lauren Lazar
Jan. 25, 2023 -
UBC crowns Bekki Brown as its new CEO with a clear mandate to grow
Jan. 20, 2023 -
Woman of the Week: Genetika+’s Talia Cohen Solal
Jan. 18, 2023 -
Woman of the Week: Form Bio’s Claire Aldridge
Jan. 11, 2023 -
Galecto has identified a master switch to reduce fibroid formation
Jan. 11, 2023 -
Gracell Biotechnologies’ quest to unlock the CAR-T bottleneck
Jan. 9, 2023